Eli Lilly’s troubled NJ manufacturing site in hot water again over maintenance, quality control lapses fkansteiner Mon, 01/22/2024 – 11:08 More: Eli Lilly's troubled NJ manufacturing site in hot water again over maintenance, quality control lapses Source: fierce
read moreCoherus sells Lucentis biosim to Sandoz for $170M to focus on oncology kdunleavy Mon, 01/22/2024 – 10:53 More: Coherus sells Lucentis biosim to Sandoz for 0M to focus on oncology Source: fierce
read moreLilly’s Jaypirca tipped to capture 60% of BTK leukemia market, leaving AstraZeneca, BeiGene in the dust ntaylor Mon, 01/22/2024 – 10:39 More: Lilly’s Jaypirca tipped to capture 60% of BTK leukemia market, leaving AstraZeneca, BeiGene in the dust Source: fierce
read moreJ&J’s Balversa gets mixed approval in bladder cancer as FDA ratchets up scrutiny on subgroup data, patient survival aliu Mon, 01/22/2024 – 10:28 More: J&J's Balversa gets mixed approval in bladder cancer as FDA ratchets up scrutiny on subgroup data,
read moreGilead’s Trodelvy fails to extend survival in lung cancer study, prompting selloff zbecker Mon, 01/22/2024 – 09:29 More: Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff Source: fierce
read moreApproximately one in five children will be hospitalised to treat measles More: NHS catch up campaign launched for missed MMR vaccines Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals